# DESCRIPTION

## FIELD OF THE INVENTION

- define field of invention

## BACKGROUND OF THE INVENTION

- introduce NSAIDs
- describe NSAIDs treatment
- describe gastropathy
- describe oxidative stress
- describe ROS generation
- describe mitochondrial pathology
- describe iron chelation
- describe serotonin role
- describe serotonin toxicity
- describe limitations of existing gastroprotective compounds
- describe proton pump inhibitors
- describe H2 receptor blockers
- describe adverse effects
- describe bacterial infection risk
- describe need for new compounds

## OBJECTIVES OF THE INVENTION

- provide compounds of general formula 1
- provide new scaffold for treatment of gastropathy

## SUMMARY OF THE INVENTION

- introduce compounds of general formula 1
- describe representative compounds
- describe antioxidant property
- describe anti-apoptotic property
- describe mitochondrial iron chelation
- describe ROS scavenging
- describe pharmaceutical composition
- describe method for treating gastropathy
- describe effective amount of compound
- describe administration route
- describe ED50 value

## DETAILED DESCRIPTION OF THE INVENTION

- synthesize tryptamine derivatives
- describe SEGA (3a) synthesis
- describe TRGA (3b) and MEGA (3c) synthesis
- describe GASA (4d) synthesis
- describe 5-hydroxy derivative 5c synthesis
- describe dimeric serotonin derivative 6c synthesis
- describe antioxidant activity of derivatives
- describe gastroprotective effect of derivatives
- describe SEGA (3a) antioxidant activity
- describe SEGA (3a) gastroprotective effect
- describe SEGA (3a) mitochondrial protective effect

### Biological Effects

- describe FRAP assay
- describe antioxidant property of tryptamine derivatives
- describe DPPH assay
- describe SEGA (3a) antioxidant property
- describe SEGA (3a) gastroprotective effect
- describe histological studies
- describe effect of other tryptamine derivatives
- describe effect of serotonin on gastropathy
- describe SEGA (3a) rescue of NSAIDs-induced damaged gastric mucosa
- describe SEGA (3a) protection of mitochondrial oxidative stress
- describe SEGA (3a) prevention of oxidative stress-induced apoptosis
- describe SEGA (3a) restoration of mitochondrial dysfunction
- describe SEGA (3a) chelation of intramitochondrial iron

## EXAMPLES

- provide examples of the present invention

### Example 1

- describe general EDC coupling procedure for formation of esters or amide

### Example 2

- describe general procedure of de benzylation (hydrogenolysis)

### Example 3

- prepare benzyl 3,4,5-tris(benzyloxy)benzoate (1a)
- prepare 3,4,5-tris(benzyloxy)benzoic acid (1b)
- prepare 3,4,5-tris(benzyloxy)-N-(2-(5-hydroxy-1H-indol-3
- describe characterization of 3,4,5-tris(benzyloxy)-N-(2-(5-hydroxy-1H-indol
- prepare 3,4,5-trihydroxy-N-(2-(5-hydroxy-1H-indol-3-yl)ethyl
- describe characterization of 3,4,5-trihydroxy-N-(2-(5-hydroxy-1H-indol-3-yl

### Example 4

- prepare (E)-N-(2-(5-hydroxy-1H-indol-3-yl)ethyl)-3-(4-hydroxy

### Example 5

- prepare 3-((2-((1H-indol-3-yl) methylamino) ethyl)-1H-indol-5

### Example 6

- prepare N-(2-(1H-indol-3-yl)ethyl)-3,4,5-tris(benzyloxy)ben
- describe characterization of N-(2-(1H-indol-3-yl)ethyl)-3,4,5-tris(benzyloxy
- prepare N-(2-(1H-indol-3-yl)ethyl)-3,4,5-trihydroxybenzamide

### Example 7

- prepare (E)-N-(2-(1H-indol-3-yl)ethyl)-3-(4-hydroxyphenyl) acry

### Example 8

- prepare N-((1H-indol-3-yl) methyl)-2-(1H-indol-3-yl)ethanamine

### Example 9

- synthesize compound 2g
- characterize compound 2g
- synthesize compound 3c
- characterize compound 3c
- synthesize compound 2h
- characterize compound 2h
- synthesize compound 2i
- characterize compound 2i
- synthesize compound 4d
- synthesize compound 4b
- characterize compound 4b
- synthesize compound 4c
- characterize compound 4c
- synthesize compound 4d
- characterize compound 4d
- synthesize compound 5a
- characterize compound 5a
- synthesize compound 6a
- characterize compound 6a
- synthesize compound 6b
- characterize compound 6b
- synthesize compound 6c
- characterize compound 6c
- describe NMR data
- describe NMR data
- describe FRAP assay
- calculate FRAP value
- describe DPPH assay
- measure antioxidant activity
- describe animal model
- induce gastric damage
- administer test compound
- measure ulcer index
- describe histology
- prepare tissue sections
- stain tissue sections
- describe healing effect
- induce gastric damage
- administer SEGA
- measure ulcer index
- isolate mitochondria
- measure mitochondrial oxidative stress
- measure protein carbonyl formation
- measure lipid peroxidation
- measure total thiol content
- measure caspase-9 and caspase-3 activities
- describe cell culture
- measure mitochondrial transmembrane potential
- measure mitochondrial dehydrogenase activity
- measure intra-mitochondrial superoxide
- measure free iron
- visualize fluorescence microscopy

## ADVANTAGES OF THE INVENTION

- list advantages

